Dr. Sabater is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
900 NW 17th St
Miami, FL 33136Phone+1 305-326-6326Fax+1 305-326-6337- Is this information wrong?
Summary
- Dr. Alfonso L. Sabater is a surgeon-scientist and Associate Professor of Clinical Ophthalmology at the Bascom Palmer Eye Institute - University of Miami Miller School of Medicine. Dr. Sabater is the Medical Director of the Ocular Surface Program and Director of the Corneal Innovation Lab at the Bascom Palmer Eye Institute. Research in his laboratory is aimed at investigating strategies for corneal and ocular surface protection and regeneration. Dr. Sabater received his MD from the University of Valencia (Spain), and his PhD from the University of Navarra (Spain). He completed his ophthalmology residency at the University of Navarra, and both an ocular surface diseases research fellowship and a cornea and external diseases clinical fellowship at the Bascom Palmer Eye Institute (USA). Dr. Sabater has several publications in leading journals and holds multiple patents. He has served as an ad hoc reviewer for several scientific journals, and he is currently a Board Member Director of the Pan-American Cornea Society (PanCornea). Dr. Sabater is also the co-founder of three University of Miami spin-off companies focused on developing therapies and devices for patients with corneal and ocular surface diseases.
Education & Training
- University of NavarraPh.D., 2016
- Universidad de Valencia Faculty of MedicineClass of 2009, M.D.
Certifications & Licensure
- FL State Medical License 2018 - 2026
Clinical Trials
- Plasma Rich in Growth Factors in Corneal Endothelial Transplantation Start of enrollment: 2024 May 15
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Novel treatments for dry eye syndrome.Esther Roucaute, Marcela Huertas-Bello, Alfonso L Sabater> ;Current Opinion in Pharmacology. 2024 Apr 1
- Efficacy of plasma rich in growth factors (PRGF) in stage 1 neurotrophic keratitis.Ghalibafan, S., Osei, K., Amescua, G., Sabater, A.> ;Eye. 2023 Dec 30
- Comparison of Transcriptomic Analysis of the Conjunctiva in Glaucoma-Treated Eyes with Dry Eyes and Healthy Controls.Carnero, E., Irigoyen-Bañegil, C., Gutiérrez, I., Extramiana, L., Moreno-Montañes, J., Sabater, A.> ;Biomolecules. 2023 Dec 25
- Join now to see all
Press Mentions
- The FDA Just Approved Rub-on Gene Therapy That Helps “Butterfly” ChildrenMay 19th, 2023
- Krystal Biotech Announces Clinical Data on Topical Application of B-VEC to the Eye to Treat Ocular Complications in a Patient with Dystrophic Epidermolysis Bullosa Under a Compassionate Use ProgramApril 24th, 2023
- Most of Today’s Gene Therapies Rely on Viruses — and That’s a ProblemOctober 21st, 2023
- Join now to see all
Hospital Affiliations
- UMHC - Bascom Palmer Eye InstituteMiami, Florida
- UMHC-Sylvester Comprehensive Cancer CenterMiami, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: